![Cancer and Inflammation (Novartis Foundation Symposia)|Chadwick, Derek J. [Editor]; Goode, Jamie A. [Editor];](https://covers3.booksamillion.com/covers/bam/0/47/085/510/047085510X.jpg)
In Stock with our New/Used Market Vendor. Allow up to 30 days for delivery. Tracking is not available for this item. FREE Shipping is not available for this item. help
Seller Information
GridFreed
North Las Vegas, NV, USA
Cancer and Inflammation (Hard cover)Pub. Date: 2004
Publisher: John Wiley & Sons
Price: $56.00
Seller: Marsarbooks, Cambridge, GBR
Description: Sewn binding. Cloth over boards. 290 p. Contains: Illustrations, references.
Condition: New. No dust jacket as issued. Excellent as new condition, perfect MINT. A brand new copy.
Cancer and Inflammation (Hard cover)Pub. Date: 2004
Publisher: John Wiley & Sons
Price: $61.00
Seller: Marsarbooks, Cambridge, GBR
Description: Sewn binding. Cloth over boards. 290 p. Contains: Illustrations, references.
Condition: New. No dust jacket as issued. Excellent as new condition, perfect MINT. A brand new copy.
Other Available Formats Seller Information Price Cancer and Inflammation (Novartis Foundation Symposia) (Hardcover)
Pub. Date: 2004
Publisher: Wiley
Description: Connecting readers with great books since 1972! Used textbooks may not include companion materials such as access codes, etc. May have some wear or writing/highlighting. We ship orders daily and Customer Service is our top priority!
Condition: Good
HPB-Red
Carrollton, TX, USA$48.05 Cancer and Inflammation: Symposium on Cancer and Inflammation, Held at the Novartis Foundation, London, 12-14 November 2002 (Hardcover)
Pub. Date: 2004
Publisher: John Wiley & Sons Inc
Description: 1st edition. 300 pages. 9.00x6.00x0.75 inches.
Condition: New
Revaluation Books
Exeter, DEVON, GBR$72.17
Chronic inflammation predisposes to some forms of cancer and the host response to malignant disease shows several parallels with inflammation and wound healing. The cells involved in inflammation are detected in a range of common cancers, together with the inflammatory cytokines and members of the chemokine ligand/receptor systems.
Neutralization or deletion of the gene for some inflammatory cytokines confers resistance to tumour induction and experimental metastasis. Over-expression of such cytokines in tumour cells may enhance malignant potential. Certain chemokines are likely to subvert antitumour immunity by favouring development of ineffective Type 2 responses. Tumour cells may even utilize chemokine receptors in homing to lymph nodes and other organs. Thus, the cells, cytokines and chemokines found in tumours are more likely to contribute to tumour growth, progression and immunosuppression than they are to mount an effective host antitumour response.
This book draws together contributions from an international group of scientists and clinicians from diverse disciplines, ranging from epidemiology to immunology, cell biology, molecular oncology, molecular medicine and pharmacology to debate these and related issues. Topics covered include the epidemiological links between cancer and inflammation, the parallels between inflammation and cancer, the role of inflammation in cancer, inflammatory genes as risk factors for cancer initiation and progression, inflammation and cancer angiogenesis, and preventative and therapeutic strategies.
Related Novartis Foundation symposia:
252 Generation and Effector Functions of Regulatory Lymphocytes
Chair: Jean-Fran¿¿¿ois Bach
254 Immunoinformatics: Bioinformatic Strategies for Better Understanding of Immune Function
Chair: Hans-Georg Rammensee